Larvol Delta - Aclaris-plans-to-start-a-study-of-ATI2138-an-oral-ITKJAK3-inhibitor-in-lichen-planus-in-the-second-half-of-the-year

ATI-2138 - Aclaris

https://www.tradingview.com/news/marketbeat:b76200fdc094b:0-aclaris-therapeutics-maps-busy-pipeline-calendar-plans-phase-2-asthma-trial-for-ati-052/

Jun 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next